U.S. Professional Services Stock News

MBIA (MBI) continues to operate at a loss, but over the last five years the company has narrowed those losses at an average annual rate of 3.2%. Despite this gradual progress, MBIA’s net profit margin is still in negative territory, and its valuation stands out. The Price-to-Sales Ratio sits at 3.5x, which is significantly higher than both the US insurance industry average of 1.1x and a peer group average of 1.3x. With profitability still out of reach and no fair value estimate available,...

CeriBell (CBLL) is forecast to grow revenue by 23.39% per year, outpacing the US market’s projected 10.5% annual increase. Despite this trajectory, the company remains unprofitable and is not expected to reach profitability within the next three years, with no evidence of net profit margin improvement over the last twelve months. Investors are likely to weigh CeriBell's robust top-line expansion against continued losses and a valuation multiple well above peers. See our full analysis for...

Stoke Therapeutics (STOK) has moved into profitability over the past year and is now forecasting revenue growth of 20.1% per year, which handily outpaces the broader US market's 10.5% annual growth expectation. However, earnings are projected to decline by 5.6% each year over the next three years, suggesting the company's recently achieved profit status may be tested as the bottom line comes under pressure. The premium valuation and mixed outlook put investor attention squarely on how...

Arista Networks (ANET) posted net profit margins of 40.9%, up from 39% last year, and delivered a strong 32.1% earnings growth over the past year. Earnings are expected to grow 16.31% annually, with revenue projected to rise 16.6% per year. Both figures comfortably outpace the broader US market's revenue outlook of 10.5%. With five-year annualized earnings growth at 35.5%, investors will be weighing these rapid gains against a recent share price of $140.42, which is notably above the...

Corsair Gaming (CRSR) reported that losses have deepened at an average rate of 68.9% per year over the past five years, reflecting mounting unprofitability even as the company forecasts 8.7% annual revenue growth, which is below the 10.5% US market average. However, with earnings expected to grow at a robust 96.57% per year and profitability projected within the next three years, Corsair is seen by some investors as a turnaround candidate. See our full analysis for Corsair Gaming. Next up, we...

Solid Power (SLDP) continues to operate at a loss, with net losses deepening at a 50.3% annual rate over the last five years. Despite persistent negative profit margins, analysts forecast revenue growth of 40.5% per year, far outpacing the US market’s 10.5% average and SLDP’s peer group. This high growth outlook is very much in focus as investors weigh it against ongoing losses and a valuation that already sits far above sector averages. See our full analysis for Solid Power. Next, we’ll see...

Astera Labs (ALAB) has just turned profitable, with forecasts calling for earnings to grow at 27.1% per year and revenue to rise 23.5% annually, both comfortably ahead of US market averages. The company’s net profit margin has flipped from negative to positive, and its high quality earnings profile comes as shares are trading at a remarkable premium: a Price-To-Sales ratio of 49.9x, well above both direct semiconductor peers and the industry average. With no major risks or insider selling...

Andersons (ANDE) grew its earnings at an average annual rate of 16.2% over the past five years, recently posting a net profit margin of 0.7% compared to last year's 0.8%. Despite these longer-term gains, the company recorded negative earnings growth for the past year, creating a notable contrast with its historical trajectory. Investors are weighing the company’s profitable track record, slight margin compression, and the possibility that shares trading at $48.48, well below the estimated...

AnaptysBio (ANAB) is forecasting revenue growth of 25.9% per year, ahead of the broader US market’s 10.5% growth rate. Despite this, the company remains unprofitable, with losses climbing at an annual pace of 29.9% over the past five years. Net profit margins and earnings quality have yet to show improvement. Shares currently trade at a Price-to-Sales ratio of 8.2x, which offers better value than the US Biotech sector average of 10.3x, but appears expensive relative to peers at 5.8x. This...

Global Medical REIT (GMRE) has posted a turnaround, moving into profitability as net profit margins improved and earnings climbed by an average of 16.9% per year over the past five years. Looking ahead, earnings are forecast to accelerate by 22.6% per year, outpacing the broader US market's expected 16% growth. However, projected revenue growth of 2.9% per year lags market averages. A one-off gain of $6.8 million played a notable role in the latest results, so investors will want to keep an...

Summit Hotel Properties (INN) remains unprofitable, with net profit margins showing no improvement over the last year. Despite the lack of accelerated profit growth, the company has reduced its losses over the past five years at a steady annual rate of 66.5%. Revenue is forecast to rise by 2.1% each year, which trails well behind the broader US market’s 10.5% pace. For value-focused investors, shares trading at $5.27, well below the estimated fair value of $17.75, create an intriguing setup...

Rigel Pharmaceuticals (RIGL) has turned profitable in the last year, with net profits reversing after a string of losses. The company’s earnings grew at an impressive 40.2% per year over the past five years, signaling high quality performance. However, forward guidance calls for a 4% annual decline in earnings over the next three years and revenue growth of just 6.5% per year, falling short of the US market’s 10.5% average. Despite upbeat profit growth, the outlook now turns on whether Rigel...

Mosaic (MOS) delivered remarkable earnings growth of 284% over the last year, a sharp turnaround from its five-year average decline of -8.4% per year. Net profit margins strengthened significantly, moving from 2% to 8.4%. However, this surge was driven in part by a one-off $652.2 million gain, making some of these earnings non-recurring. Looking ahead, sentiment will weigh Mosaic’s low Price-to-Earnings Ratio of 8.9x and pricing below analyst fair value estimates against the forecast for...

Postal Realty Trust (PSTL) delivered a net profit margin of 10.4%, a substantial leap from last year’s 2.7%, as robust earnings fueled a 377.6% jump in growth over the past year. The company has built a five-year track record of consistent profitability gains and, looking forward, earnings are projected to grow at roughly 10% annually with revenue forecast to rise 11.5% per year, ahead of the general US market. Investors are weighing these strong margin improvements and sustained profit...

Latham Group (SWIM) is currently unprofitable, with expectations to turn profitable within the next three years. Earnings are forecast to grow quickly at 46.36% per year, significantly outpacing the broader market. Revenue is projected to rise by 4.8% per year, which is a much slower pace than the US market's 10.5%. The company has steadily reduced its losses by an annual rate of 13.7% over the past five years. While the Price-to-Sales Ratio sits well above industry peers at 1.6x, shares are...

Axon Enterprise (AXON) posted eye-catching forecasts, with revenue expected to grow 21.6% annually, significantly outpacing the broader US market’s 10.5% rate. EPS is also projected to rise sharply by 55.2% per year. However, the company’s net profit margin slipped to 13.6% from 16.2% last year, and its most recent annual earnings growth of 11.3% is below its five-year average of 59.9%. The results also include a sizable one-off gain of $197.6 million, which complicates the assessment of the...

Navitas Semiconductor (NVTS) is forecasting standout growth, with revenue expected to rise 26.6% per year. This is more than double the broader US market’s 10.5% annual pace. Despite that top-line momentum, the company remains unprofitable, with losses having deepened at a rate of 22.5% per year over the past five years and no signs yet of margins improving. Investors now face the lure of rapid revenue growth, weighed against persistent unprofitability and the stock’s hefty valuation premium...

Finance of America Companies (FOA) reported losses that have deepened at a 15.4% annual rate over the past five years, while net profit margin remains under pressure, there are some positives for investors. While GAAP earnings for Q3 2025 came in at -$29 million, Adjusted Net Income (ANI) was $33 million, reflecting the exclusion of non-cash fair-value changes and other non-recurring items that management does not believe are representative of core operations...

International General Insurance Holdings (NasdaqCM:IGIC) reported steady profitability with EPS growth averaging 30.9% annually over the past five years. Net profit margin improved to 23.3% from last year’s 22.6%, while earnings for the past year rose 13.2%, trailing its five-year trend. At a share price of $22.46, the stock trades well below the estimated fair value of $30.41. IGIC’s price-to-earnings ratio of 7.8x is also well under both industry and peer averages. With no risks highlighted...

Clearway Energy (CWEN.A) posted a net profit margin of 5.3%, a decline from last year’s 7.2%. Average earnings growth over the past five years has been just 1.2% per year, but the most recent results show negative year-over-year earnings growth. Looking ahead, earnings are forecast to grow at an impressive 23.1% annually, which is well ahead of the US market average. Revenue is expected to rise 9.6% per year, slightly lagging the broader market. Investors face mixed signals as the stock...

Entravision Communications (EVC) continues to struggle with profitability, posting net losses that have widened over the past five years at an annual rate of 69.7%. The company’s net profit margin shows no sign of improvement while it remains unprofitable, and recent earnings trends do not offer any evidence that profit growth has picked up. The data highlights mounting risks for investors, with high and rising losses overshadowing any potential rewards at this stage. See our full analysis...

Flywire (FLYW) has posted a sharp turnaround, swinging to profitability with net profit margins improving over the last year and earnings growing at an impressive 40.3% per year for the past five years. While the company registered a sizable one-off loss of $6.5 million for the twelve months ending September 30, 2025, revenue is projected to increase at 13.7% per year and earnings are forecast to soar 68.1% per year, both comfortably ahead of US market averages. These trends highlight a...

Vertex Pharmaceuticals (VRTX) is forecasting revenue growth of 8.8% annually, trailing the broader US market’s 10.5% pace. Earnings are expected to rise 13.3% per year, slower than the US average of 16%. Over the past five years, the company’s earnings have actually declined by 10.4% per year, yet Vertex recently moved into profitability and has improved its net profit margins. This puts a spotlight on ongoing improvements in earnings quality this season. See our full analysis for Vertex...

Jackson Financial (JXN) posted a net loss, with losses having deepened at a rate of 14.3% per year over the past five years. Looking ahead, analysts project revenue growth of 2.4% per year and earnings growth of 5.68% annually, with JXN expected to reach profitability within the next three years. For investors, these figures signal that the current unprofitability may be a temporary challenge. A turnaround could be on the horizon as earnings are forecast to improve. See our full analysis for...